Vanguard Personalized Indexing Management
IBRX icon

Vanguard Personalized Indexing Management’s ImmunityBio IBRX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$231K Sell
26,419
-2,298
-8% -$17.4K ﹤0.01% 1838
2026
Q1 		$220K Buy
28,717
+14,959
+109% +$102K ﹤0.01% 1768
2025
Q4 		$27.2K Buy
13,758
+1,057
+8% +$2.4K ﹤0.01% 1925
2025
Q3 		$31.2K Sell
12,701
-2,730
-18% -$7.03K ﹤0.01% 1948
2025
Q2 		$40.7K Buy
15,431
+379
+3% +$1.02K ﹤0.01% 1852
2025
Q1 		$45.3K Sell
15,052
-1,690
-10% -$5.12K ﹤0.01% 1685
2024
Q4 		$42.9K Buy
16,742
+2,806
+20% +$11.7K ﹤0.01% 1711
2024
Q3 		$51.8K Sell
13,936
-1,938
-12% -$8.97K ﹤0.01% 1675
2024
Q2 		$100K Buy
15,874
+474
+3% +$3.13K ﹤0.01% 1527
2024
Q1 		$82.7K Sell
15,400
-1,378
-8% -$6.24K ﹤0.01% 1534
2023
Q4 		$84.2K Sell
16,778
-4,828
-22% -$15.1K ﹤0.01% 1486
2023
Q3 		$36.5K Buy
+21,606
New +$43.4K ﹤0.01% 1421
2021
Q4 		– Sell
-15,446
Closed -$150K – 1082
2021
Q3 		$150K Buy
+15,446
New +$170K 0.01% 943

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Personalized Indexing Management's IBRX Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its ImmunityBio (IBRX) stake by 8% in Q2 2026, selling an estimated $17.4K and leaving 26,419 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #1838.

Vanguard Personalized Indexing Management first reported a position in IBRX in Q3 2021 and has held it in 13 quarters since. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Vanguard Personalized Indexing Management held 26,419 shares of ImmunityBio worth $231K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 2,298 ImmunityBio shares in Q2 2026, an estimated $17.4K.
  • ImmunityBio made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1838 holding.
  • Vanguard Personalized Indexing Management first reported a position in ImmunityBio in Q3 2021 and has held it in 13 quarters since.
  • 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.